[1] Santarelli A,Lo Russo L,Bambini F,et al. New perspectives in medical approach to therapy of head and neck squamous cell carcinoma[J]. Minerva Stomatol,2009,58:445-452. [2] Mehanna H,Paleri V,West CML,et al. Head and neck cancer-Part 1:epidemiology,presentation,and prevention[J].BMJ,2010,341:663-666. [3] Chaturvedi AK,Engels EA,Anderson WF,et al. Incidence trends for human papillomavirus-related and unrelated oral squamous cell carcinomas in the United States[J]. J Clin Oncol,2008,26:612-619. [4] 徐国镇,高黎,易俊林,等[A]//殷蔚伯,余子豪,徐国镇,等.肿瘤放射治疗学[M].北京:中国协和医科大学出版社,2008:324-426. [5] 林涛,张云艳,初明,等.γH2AX在HPVl6阳性宫颈鳞癌组织中的表达及意义[J].中华微生物学和免疫学杂志,2012,32:134-139. [6] Licitra L,Perrone F,Bossi P,et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma[J].J Clin Oncol,2006,24:5630-5636. [7] Fakhry C,Westra WH,Li S,et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial[J].J Natl Cancer Inst,2008,100:261-269. [8] Lin BM,Wang H,D′Souza G,et al. Long-term prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma[J].Cancer,2013,119:3462-3471. [9] Klussmann JP,Mooren JJ,Lehnen M,et al. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications[J]. Clin Cancer Res,2009,15:1779-1786. [10] Martinez I,Wang J,Hobson KF,et al. Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas[J].Eur J Cancer,2007,43:415-432. [11] Wilson DD,Rahimi AS,Saylor DK,et al. p16 Not a prognostic marker for hypopharyngeal squamous cell carcinoma arch otolaryngol[J]. Head Neck Surg,2012,138:556-561.
2014, Vol. 23 
